Breast implants carry increased lymphoma risk for rare few

BREAST IMPLANTS CANCER t

Raylene Hollrah was 33, with a young daughter, when she learned she had breast cancer. She made a difficult decision, one she hoped would save her life: She had her breasts removed, underwent grueling chemotherapy and then had reconstructive surgery.

 

In 2013, six years after her first diagnosis, cancer struck again — not breast cancer, but a rare malignancy of the immune system — caused by the implants used to rebuild her chest.

IMPLANT master
Nearly all the cases of breast implant-associated anaplastic large-cell lymphoma have been linked to textured implants like this one.

Her disease — breast implant-associated anaplastic large-cell lymphoma — is a mysterious cancer that has affected a tiny proportion of the more than 10 million women worldwide who have received implants.

The Food and Drug Administration first reported a link between implants and the disease in 2011, and information was added to the products’ labeling.

What exactly causes the disease is not known. One theory is that bacteria may cling to textured implants and form a coating called a biofilm that stirs up the immune system and causes persistent inflammation, which may eventually lead to lymphoma.

Another possible cause is that some women have a genetic trait that somehow, in the presence of implants, predisposes them to lymphoma.

The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion, and analysis. Read full, original post: A shocking diagnosis: Breast implants ‘gave me cancer’

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Screenshot-2026-04-23-at-11.00.36-AM
Regulators' dilemma: Thalidomide, Metformin, and the cost of getting drug approvals wrong
Picture1-5
Science Disinformation Gap: The transatlantic battle over social media and censorship
ChatGPT-Image-May-13-2026-11_56_08-AM
After slashing global health aid by $19 Billion, Trump moves to tap $2.1 billion more—to cover shutdown costs
ChatGPT-Image-May-12-2026-08_39_41-PM
GLP podcast: Big Pharma, Big Ag, Big Food—health harming industries or life-saving innovators?
ChatGPT Image May 10, 2026, 08_16_59 PM 2
Overmedicalization? RFK Jr.’s antidepressant crackdown raises conflict questions over his fee stake in Wisner Baum, the tort firm built on suing drug makers
Screenshot-2026-05-12-at-9.58.31-PM
'He seems fine': Marty Makary out as FDA commissioner
Screenshot-2026-05-01-at-1.29.41-PM
Viewpoint: What happens when whole grains meet modern food manufacturing? Labels don’t tell the whole story.
ChatGPT-Image-Apr-13-2026-02_20_22-PM
Viewpoint: Misinformation infodemic? Why assessing evidence is so challenging 
Picture1-1
Cooling the planet with balloons: Could a geoengineering gamble slow global warming?
S
As vaccine rejectionism spreads, measles may be taking a more dangerous turn
Screenshot-2026-05-11-104424
Hantavirus outbreak research: Trump administration shut down study last year on rodent-to-human transmission
Screenshot-2026-05-12-at-10.05.11-AM
Pro-vaccine “hero” vs. an anti-vax “villain”: ‘Bad Vaxx’ video stirs MAHA backlash
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.